Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/52002
| Campo DC | Valor | idioma |
|---|---|---|
| dc.contributor.author | Wägner, Ana María | en_US |
| dc.date.accessioned | 2018-11-25T16:36:46Z | - |
| dc.date.available | 2018-11-25T16:36:46Z | - |
| dc.date.issued | 2015 | en_US |
| dc.identifier.isbn | 9783642370786 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10553/52002 | - |
| dc.description.abstract | Neuroendocrine cells in the gut secrete peptide hormones with a central role in digestion, metabolism and appetite regulation. More recently, some of these peptides have shown potential therapeutic value related to their effects on the cardiovascular system. The most promising examples are the incretin GLP-1, whose analogues and breakdown inhibitors are currently being used in the treatment of type 2 diabetes, and ghrelin, which might play a role in the future treatment of anorexia and weight loss in patients with chronic heart failure. | en_US |
| dc.language | eng | en_US |
| dc.publisher | Springer | en_US |
| dc.relation.ispartof | PanVascular Medicine, Second Edition | |
| dc.source | PanVascular Medicine / Peter Lanzer (ed.), p. 4695-4703 | en_US |
| dc.subject | 32 Ciencias médicas | en_US |
| dc.subject | 320502 Endocrinología | en_US |
| dc.subject.other | Bile Acid | en_US |
| dc.subject.other | Chronic Heart Failure | en_US |
| dc.subject.other | DPP4 Inhibitor | en_US |
| dc.subject.other | Short Bowel Syndrome | en_US |
| dc.subject.other | Final Infarct Size | en_US |
| dc.title | Gut Hormones and the Vascular System | en_US |
| dc.type | info:eu-repo/semantics/bookPart | en_US |
| dc.type | BookPart | en_US |
| dc.identifier.doi | 10.1007/978-3-642-37078-6_196 | en_US |
| dc.identifier.scopus | 84957039858 | - |
| dc.contributor.authorscopusid | 7401456520 | - |
| dc.description.lastpage | 4703 | en_US |
| dc.description.firstpage | 4695 | en_US |
| dc.investigacion | Ciencias de la Salud | en_US |
| dc.type2 | Capítulo de libro | en_US |
| dc.description.numberofpages | 9 | en_US |
| dc.utils.revision | Sí | en_US |
| dc.identifier.ulpgc | Sí | en_US |
| dc.identifier.ulpgc | Sí | en_US |
| dc.identifier.ulpgc | Sí | en_US |
| dc.identifier.ulpgc | Sí | en_US |
| dc.contributor.buulpgc | BU-MED | en_US |
| dc.contributor.buulpgc | BU-MED | en_US |
| dc.contributor.buulpgc | BU-MED | en_US |
| dc.contributor.buulpgc | BU-MED | en_US |
| dc.description.spiq | Q1 | |
| item.grantfulltext | none | - |
| item.fulltext | Sin texto completo | - |
| crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
| crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
| crisitem.author.dept | Departamento de Ciencias Médicas y Quirúrgicas | - |
| crisitem.author.orcid | 0000-0002-7663-9308 | - |
| crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
| crisitem.author.fullName | Wägner, Anna Maria Claudia | - |
| Colección: | Capítulo de libro | |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.